Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
07 févr. 2013 14h36 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Reports Net Sales of $4.0 Million for Third Quarter of Fiscal 2013
28 janv. 2013 17h15 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Release Date of Third Quarter of Fiscal 2013 Results
21 janv. 2013 07h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Jan. 21, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences to Present at Lazard Capital Markets 9th Annual Healthcare Conference
08 nov. 2012 08h49 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Reports Net Sales of $3.7 Million for Second Quarter of Fiscal 2013
05 nov. 2012 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Reschedules Release Date of Second Quarter of Fiscal 2013 Results Due to Expected Severe Weather Conditions
29 oct. 2012 10h28 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Oct. 29, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announces the postponement of today's release of its second quarter fiscal 2013 financial results and conference...
Vision-Sciences Announces Release Date of Second Quarter of Fiscal 2013 Results
22 oct. 2012 07h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Research Study Results Demonstrate Advantages of Vision-Sciences' EndoSheath(R) Technology for Bronchoscopy
01 août 2012 07h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Reports Revenues of $3.4 Million for First Quarter 2013
26 juil. 2012 07h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., July 26, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Release Date of First Quarter of Fiscal 2013 Results
23 juil. 2012 20h56 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., July 23, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...